Recent 8-K filings for ELOX

• June 1, 2026, 7:00 AM ET other material materiality 0.75 negative item 3.02item 3.03item 5.03item 5.02item 9.01

  Eloxx Pharma: 1-for-11 reverse stock split effective May 29; appoints two independent directors

  Board approved 1-for-11 reverse stock split effective May 29, 2026; authorized shares reduced from 500M to 100M.

• May 1, 2026, 7:59 PM ET other material materiality 0.60 neutral item 5.07

  Stockholders approve reverse split range, authorized share reduction, equity plan amendments via written consent

  Ratified amendment to 2018 Equity Plan: shares available increased to 20M, ISO limit to 30M.

• July 16, 2024, 7:59 PM ET debt materiality 0.70 negative item 1.01item 2.03

  Eloxx enters $3.2M debt amendment with Hercules and Domicilium; Royalty obligations up to $53M

  Tranche 2 Advance of $3.175M provided under Sixth Amendment to Hercules loan; Bridge Loan of $288k also made.

Executive changes

Materiality & sentiment trend

Max materiality 0.75 · Median 0.60 · Most common event other_material

0 positive 2 negative 3 neutral

source · ELOX on sec.gov